AVITA Medical Stock Is Moving: Shareholder Votes Put Cash, Warrants and Wound-Care Growth in Focus
AVITA Medical shares edged higher on Friday after stockholders backed a package of board, pay and financing measures, including director equity awards and warrants tied to a lender, shifting attention to how the wound-care company funds its next phase of growth. The stock was up 0.8% at $4.395 in early U.S. trading, according to a Cboe BZX estimate carried by MarketScreener. The vote matters now because AVITA is trying to move from stabilization to steadier execution after a choppy period for reimbursement, the payment system through which insurers or Medicare contractors set how clinicians are paid for using a product. In May, the company said first-quarter revenue rose 4% from a year earlier to $19.3 million and 10% from the